| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Zhang,Ming-Zheng | Chairman | 40.00% | EXCELSIOR MEDICAL CO., LTD. |
| Fu,Ruo-Xuan | Director | 0.00% | |
| Zhang,Xian-Zheng | Director | 40.00% | EXCELSIOR MEDICAL CO., LTD. |
| Zhou,Chen-Xiao | Director | 40.00% | EXCELSIOR MEDICAL CO., LTD. |
| Xue,Fu-Quan | Director | 0.00% | JIA YI INVESTMENT CO., LTD. |
| Su,Wen-Lin | Director | 0.00% | XUAN HUI INVESTMENT CO., LTD. |
| Wang,Chang-Sheng | Independent Director | 0.00% | |
| Xu,Shui-Sheng | Independent Director | 0.00% | |
| Dong,De-Tai | Independent Director | 0.00% |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 393,801 | 1,297,767 | 1,140,078 |
| Operating cost | 310,332 | 1,044,825 | 906,589 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 83,469 | 252,942 | 233,489 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 83,469 | 252,942 | 233,489 |
| Operating expenses | 50,879 | 157,750 | 151,591 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | 32,590 | 95,192 | 81,898 |
| Non-operating income and expenses | 3,002 | 20,642 | 13,600 |
| Net profit (loss) before tax | 35,592 | 115,834 | 95,498 |
| Income tax expense (benefits) | 6,924 | 21,974 | 18,966 |
| Net profit (loss) of ongoing business for the current period | 28,668 | 93,860 | 76,532 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 28,668 | 93,860 | 76,532 |
| Other comprehensive profit (loss), net | -5,419 | -126,870 | 112,542 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 23,249 | -33,010 | 189,074 |
| Net profit (loss) attributable to owners of parent company | 28,668 | 93,860 | 76,532 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | - | - | - |
| Comprehensive profit (loss) attributable to owners of parent company | 23,249 | -33,010 | 189,074 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
| Basic earnings per share (yuan) | 0 | 1 | 1 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | -1,499,171 | 2,150,107 | -274,449 |
| Net cash inflows (outflows) from investing activities | 14,060 | -68,489 | -68,536 |
| Net cash inflow (outflow) from financing activities | -14,548 | -407,121 | 206,399 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
| Increase (decrease) in cash and cash equivalents in the current period | -1,499,659 | 1,674,497 | -136,586 |
| Beginning balance of cash and cash equivalents | 2,228,637 | 554,140 | 690,726 |
| Ending balance of cash and cash equivalents | 728,978 | 2,228,637 | 554,140 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 4,750,866 | 6,464,006 | 4,978,887 |
| Non-current asset | 621,822 | 639,998 | 644,117 |
| Total asset | 5,372,688 | 7,104,004 | 5,623,004 |
| Current liability | 3,388,256 | 5,041,639 | 3,569,524 |
| Non-current liability | 128,940 | 141,513 | 31,034 |
| Total liability | 3,517,196 | 5,183,152 | 3,600,558 |
| share capital | 745,744 | 745,744 | 745,744 |
| Equity - secruity token | - | - | - |
| capital reserve | 655,420 | 655,420 | 655,420 |
| retained earning | 209,348 | 269,289 | 239,418 |
| Other equity | 244,980 | 250,399 | 381,864 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 1,855,492 | 1,920,852 | 2,022,446 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | - | - |
| Total Equity | 1,855,492 | 1,920,852 | 2,022,446 |
| Share capital awaiting retirement (unit: share) | 0 | 0 | 0 |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 24 | 25 | 27 |
Return deposit
2020
Liquidation event
2021
Repay security deposit
2020
Others
2004, 2017
Disclaimer
2021
Payment order
2011, 2012, 2013, 2014, 2019, 2020, 2021, 2022
Payment, etc.
2003, 2004, 2007, 2013, 2017
Pay the ticket
2005, 2006, 2007, 2012
Pay for the goods
2001, 2003, 2005, 2006, 2007, 2008, 2013, 2014, 2018, 2019, 2020, 2021, 2022, 2024
Business encroachment
2000
Invalidating Judgment
2004, 2006, 2008, 2009, 2010, 2012, 2018, 2023
Promissory note ruling
2006, 2007, 2009, 2011, 2012, 2014, 2015, 2016, 2017, 2020
Compensation for damage
2004, 2006, 2007
Petition for disclaimer
2021
Return security deposit
2006, 2007, 2008
Determine legal expenses
2021
Business encroachment, etc.
2014
Invalidating Judgment (Note)
2012
Compensation for damage, etc.
2006, 2007
Tort damages compensation, etc.
2006
Petition filed for public summons
2008, 2009, 2010, 2011, 2018, 2022
Appointment of estate administrators
2012
Profit-seeking Enterprise Income Tax
2017
Confirmation of the existence of debt
2009
